Risks and benefits of hormone replacement therapy

Cephalalgia

Volumn 20, Issue 3, 2000, Pages 164-169

  De Lignieres B ^b,c   MacGregor, E A ^a  

^a HÂpital Necher   (France)

^b City of London Migraine Clinic   (United Kingdom)

^c Pavillon Apert ^*  (France)

Author keywords

Benefits; Hormone replacement therapy; Oestradiol; Progestins; Risks

Indexed keywords

ESTROGEN; PROGESTERONE;

ARTERY INTIMA; ARTICLE; BREAST CANCER; CARDIOVASCULAR RISK; DRUG EFFECT; ENDOMETRIUM CANCER; FEMALE; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; MENOPAUSE; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CHEMISTRY, PHARMACEUTICAL; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; OSTEOPOROSIS, POSTMENOPAUSAL; PROGESTERONE; RISK ASSESSMENT;

EID: 0034454532     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00037.x     Document Type: Article

References (51)

1. Cellular characterization of adipose tissue from body sites of women
2. Estrogen synthesis, estrogen metabolism and functional estrogen receptors in rat arterial smooth muscle cells in culture
3. Local estradiol metabolism in osteoblast- and osteoclast-like cells
4. Hormone replacement therapy
5. The case for a non plasma lipoproteins etiology of vascular risk in estrogen replacement therapy
6. Has HRT come of age?
7. Influence of sex hormones on hyperplasia/carcinoma risks
8. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: A model for the premenstrual syndrome
9. Estrogen replacement therapy must be customized
10. When does estrogen replacement therapy improve sleep quality?
11. Can climacteric women self-adjust therapeutic estrogen doses using symptoms as markers?
12. New perspectives on the skeletal role of estrogen
13. Bone mineral density and risk of breast cancer in older women
14. Endogenous hormones and the risk of hip and vertebral fractures among older women
15. Hormone replacement therapy and risk of hip fracture: Population based case-control study
16. Cause-specific mortality in women receiving hormone replacement therapy
17. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
18. Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women
19. Hormone replacement therapy and heart disease prevention
20. Hormone replacement therapy again
21. Risk of venous thromboembolism in users of hormone replacement therapy
22. Prospective study of exogenous hormones and risk of pulmonary embolism in women
23. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
24. Hormone replacement therapy and risk of non-fatal stroke
25. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
26. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
27. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
28. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
29. Coagulation activation following estrogen administration to postmenopausal women
30. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women
31. Transdermal estrogen replacement therapy: Beneficial effects on hemostatic risk factors for cardiovascular disease
32. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness
33. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women
34. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle
35. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy
36. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
37. The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease
38. Postmenopausal hormone use and risk of large bowel cancer
39. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
40. Estrogen replacement therapy and mortality among older women
41. Estrogen-progestin replacement therapy and endometrial cancer
42. Menopausal hormone use and endometrial cancer, by tumor grade and invasion
43. Hormone replacement therapy and endometrial cancer: Are current regimens safe?
44. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
45. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo
46. Estradiol and progesterone regulate the proliferation of human breast epithelial cells
47. Do different hormone replacement therapy regimens have different mammographic effects
48. HRT and breast cancer
49. Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy
50. Prognostic characteristics in breast cancers after hormone replacement therapy
51. Hormone replacement therapy and biological aggressiveness of breast cancer